ArticleBMC neurology2025
Associations between serum lipid levels and cognitive impairment in hypertensive patients: a case-control study.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePrevious studies have shown that lower serum lipid levels are associated with the development of cognitive impairment (CI), dementia, and Alzheimer's disease. However, the relationship between serum lipid levels and CI in hypertensive patients has not been determined. This case-control study aimed to investigate the relationship between serum lipid levels and CI in hypertensive patients.
methodsA total of 1840 hypertensive patients (age: 69.70 ± 6.07; sex: male: 908/49.35%) were enrolled in this study, including 460 hypertensive patients with CI and 1380 hypertensive patients with normal cognitive function matched 1:3 by age and sex. The cognitive function and sleep quality of hypertensive patients were assessed using the Mini-mental State Examination (MMSE) and Pittsburgh Sleep Quality Index (PSQI). The relationship between serum lipid levels and CI in hypertensive patients was analyzed using multifactorial logistic regression. Spearman's correlation coefficient was used to analyze the correlation of serum lipid levels with MMSE scores and PSQI total scores in hypertensive patients.
resultsAfter adjusting for all factors, serum low-density lipoprotein cholesterol (LDL-C) levels were negatively correlated with CI in hypertensive patients (OR = 0.823, 95%CI: 0.729-0.928, P = 0.001), and this association remained significant in patients with at least a junior high school education (OR = 0.727, 95%CI: 0.592-0.894, P = 0.002). However, serum total cholesterol (TC) and triglyceride (TG) levels were not correlated with CI in patients with hypertension (P > 0.05). In addition, serum LDL-C levels were positively correlated with MMSE total score (r = 0.139, P < 0.001), orientation (r = 0.118, P < 0.001), memory (r = 0.057, P = 0.014), attention and numeracy (r = 0.091, P < 0.001), recall ability (r = 0.065, P = 0.005), and language ability (r = 0.107, P < 0.030); serum TG, TC, and LDL-C levels were negatively correlated with PSQI total score (r = - 0.051, P = 0.029; r = - 0.090, P < 0.001; r = - 0.082, P < 0.001).
conclusionLower serum LDL-C levels are associated with CI in hypertensive patients. Although causality cannot be inferred, findings suggest that LDL-C may be a relevant biomarker in cognitive screening. Therefore, serum lipid levels should be reasonably controlled according to their individual conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.